Cargando…
OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767548/ http://dx.doi.org/10.1186/1742-4690-6-S3-O27 |
| _version_ | 1782173319737376768 |
|---|---|
| author | Currier, JR De Souza, M Ratto-Kim, S Paris, R Nguay, V Cox, J Earl, P Moss, B Sriplienchan, S Thongcharoen, P Kim, J Robb, M Michael, N Marovich, M |
| author_facet | Currier, JR De Souza, M Ratto-Kim, S Paris, R Nguay, V Cox, J Earl, P Moss, B Sriplienchan, S Thongcharoen, P Kim, J Robb, M Michael, N Marovich, M |
| author_sort | Currier, JR |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2767548 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27675482009-10-28 OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial Currier, JR De Souza, M Ratto-Kim, S Paris, R Nguay, V Cox, J Earl, P Moss, B Sriplienchan, S Thongcharoen, P Kim, J Robb, M Michael, N Marovich, M Retrovirology Oral Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767548/ http://dx.doi.org/10.1186/1742-4690-6-S3-O27 Text en Copyright © 2009 Currier et al; licensee BioMed Central Ltd. |
| spellingShingle | Oral Presentation Currier, JR De Souza, M Ratto-Kim, S Paris, R Nguay, V Cox, J Earl, P Moss, B Sriplienchan, S Thongcharoen, P Kim, J Robb, M Michael, N Marovich, M OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial |
| title | OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial |
| title_full | OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial |
| title_fullStr | OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial |
| title_full_unstemmed | OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial |
| title_short | OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial |
| title_sort | oa04-03. characterization of cell-mediated immune responses generated by recombinant modified vaccinia ankara (rmva)-hiv-1 in a phase i vaccine trial |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767548/ http://dx.doi.org/10.1186/1742-4690-6-S3-O27 |
| work_keys_str_mv | AT currierjr oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT desouzam oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT rattokims oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT parisr oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT nguayv oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT coxj oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT earlp oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT mossb oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT sriplienchans oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT thongcharoenp oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT kimj oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT robbm oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT michaeln oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial AT marovichm oa0403characterizationofcellmediatedimmuneresponsesgeneratedbyrecombinantmodifiedvacciniaankararmvahiv1inaphaseivaccinetrial |